Impaired Inactive to Active Kallikrein Conversion in Human Salt-Sensitive Hypertension

Journal of the American Society of Nephrology

Volumn 7, Issue 12, 1996, Pages 2565-2577

  Bellini, Cesare ^a,c   Ferri, Claudio ^b   Carlomagno, Antonio ^b   Necozione, Stefano ^c   Lepore, Anna R ^c   Desideri, Giovambattista ^b   Santucci, Anna ^c  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Blood pressure; Kallikrein kinin system; Kidney; Sodium

Indexed keywords

ATRIAL NATRIURETIC FACTOR; DIGITALIS LIKE FACTOR; INSULIN; KALLIKREIN; SODIUM CHLORIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; HORMONE BLOOD LEVEL; HUMAN; HUMAN CELL; KALLIKREIN KININ SYSTEM; MALE; PRIORITY JOURNAL; SALT INTAKE; URINARY EXCRETION;

EID: 0030377866     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Bhoola KD, Figueroa CD, Worthy K: Bioregulation of kinins: Kallikreins, kininogens, and kininases. Pharmacol Rev 1992;44:1-80.
2. Berry TD, Hasstedt SJ, Hunt SC, et al.: A gene for high urinary kallikrein may protect against hypertension in Utah kindreds. Hypertension 1989;13:3-8.
3. Bonner G, Thieven B, Rutten H, Chrosch R, Krone W: Renal kallikrein is a determinant of salt sensitivity. J Hypertens 1993;11[Suppl 5]:S210-S211.
4. Ferri C, Carlomagno A, Bellini C, Perrone A, Santucci A: Urinary kallikrein and salt sensitivity in essential hypertensive males. Kidney Int 1994;46:780-788.
5. Oza NB, Lieberthal W, Bernard DB, Levinsky NG: Antibody that recognizes total human urinary kallikrein: Radioimmunological determination of inactive kallikrein. J Immunol 1981;126:2361-2364.
6. Nishimura K, Shimizu H, Kokubu T: Existence of prokallikrein in the kidney: Its biochemical properties compared to three active glandular kallikreins from the kidney, serum, and urine of the rat. Hypertension 1983; 5:205-210.
7. Madeddu P, Oppes M, Soro A, et al.: The effects of aprotinin, a kallikrein inhibitor, on renin release and urinary sodium excretion in mild essential hypertensives. J Hypertens 1987;5:581-586.
8. Arbeit L, Serra SR: Decreased total and active urinary kallikrein in normotensive Dahl salt susceptible rats. Kidney Int 1985;28:440-446.
9. Ferri C, Bellini C, Carlomagno A, Desideri G, Santucci A: Active kallikrein response to changes in sodium chloride intake in essential hypertensive patients. J Am Soc Nephrol 1996;7:443-453.
10. Hunt SC, Hasstedt SJ, Wu LL, Williams RR: A gene environment interaction between inferred kallikrein genotype and potassium. Hypertension 1993;22:161-168.
11. Bigazzi R, Bianchi S, Baldari D, Sgherri G, Baldari G, Campese VM: Microalbuminuria in salt-sensitive patients: A marker for renal and cardiovascular risk factors. Hypertension 1994;23:195-199.
12. Leonetti Luparini R, Ferri C, Santucci A, Balsano F: Atrial natriuretic peptide in non-modulating essential hypertension. Hypertension 1993;21:803-809.
13. Sharma AM, Ruland K, Spies KP, Distler A: Salt sensitivity in young normotensive subjects is associated with hyperinsulinemic response to oral glucose. J Hypertens 1991;9:329-335.
14. Overlack A, Ruppert M, Kolloch R, et al.: Divergent hemodynamic and hormonal responses to varying salt intake in normotensive subjects. Hypertension 1993;22: 331-338.
15. Ferri C, Bellini C, Baldoncini R, et al.: Abnormal atrial natriuretic peptide and renal responses to saline infusion in nonmodulating essential hypertensive patients. Circulation 1994;90:2859-2869.
16. The Guidelines Subcommittee of the WHO/ISH Mild Hypertension Liaison Committee: 1993 Guidelines for the Management of Mild Hypertension [Memorandum from a World Health Organization/International Society of Hypertension Meeting]. Hypertension 1993;22:393-403.
17. 23Na-NMR study of cation cotransport in human red blood cells. Am J Physiol 1982;262(Cell Physiol):1292-1296.
18. Friedewald WT, Levy R, Frederickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge. Clin Chem 1972;18:499-502.
19. Amundsen E, Putter J, Friberger P, Knos M, Larsbroten M, Claeson G: Methods for the determination of glandular kallikrein by means of a chromogenic tripeptide substrate. Adv Exp Med 1979;102A:83-95.
20. Takahashi S, Irie A, Katayama Y, Ito K, Miyake Y: N-terminal amino acid sequence of human urinary prokallikrein. J Biochem 1986;99:989-992.
21. Campese VM: Salt sensitivity in hypertension: Renal and cardiovascular implications. Hypertension 1994;23: 531-550.
22. Sullivan JM: Salt sensitivity: Definition, conception, methodology, and long-term issues. Hypertension 1991; 17[Suppl I]:I61-I68.
23. Ideishi M, Shin-Ichiro M, Sakai T, Sasaguri M, Misumi Y, Arakawa K: Taurine amplifies renal kallikrein and prevents salt-induced hypertension in Dahl rats. J Hypertens 1994;12:653-661.
24. Bouhnik J, Richoux JP, Huang H, et al.: Hypertension in Dahl-salt sensitive rats: Biochemical and immunohistochemical studies. Clin Sci 1992;83:13-22.
25. Pravenec M, Kren V, Kunes J, et al.: Cosegregation of blood pressure with a kallikrein gene family polymorphism. Hypertension 1991;17:242-246.
26. Rapp JP, McPartland RP, Batten CL: Isoelectric focusing patterns of urinary kallikrein in Dahl salt-hypertension susceptible and resistant rats. Hypertension 1984;6: 519-525.
27. Shimamoto K, Masuda A, Ando T, et al.: Mechanisms of suppression of renal kallikrein activity in low renin essential hypertension and renoparenchymal hypertension. Hypertension 1989;14:375-378.
28. Sealey JE, Cholst J, Glorioso N, et al.: Sequential changes in plasma luteinizing hormone and plasma prorenin during the menstrual cycle. J Clin Endocr Metab 1987;63:1-5.
29. Atlas SA, Maack T: Effects of atrial natriuretic factor on the kidney and the renin-angiotensin-aldosterone system. Endocrinol Metab Clin North Am 1987;116:107-143.
30. Campese VM, Romoff MS, Levitan D, Saglikes Y, Massry SG: Abnormal relationship between sodium intake and sympathetic nervous system activity in salt sensitive patients with essential hypertension. Kidney Int 1982; 21:371-378.
31. Lang RE, Thoelken H, Ganten D, Luft FC, Ruskoaho H, Unger TH: Atrial natriuretic factor is a circulating hormone, stimulated by sodium loading. Nature 1985;314: 264-266.
32. Dichtchekenian V, Giser S, Quental I, Santos SRCJ, Marcondes M, Heiman JC: Higher salt consumption, digoxin-like factor, and nifedipine response are associated with salt sensitivity in essential hypertension. Am J Hypertens 1992;5:707-712.
33. Cacciafesta M, Ferri C, Carlomagno A, et al.: Increased sodium, potassium cotransport activity in salt-sensitive essential hypertensive patients. J Hypertens 1993; 11[Suppl 5]:S254-S255.
34. Canessa M, Bize I, Spalvins A, Falkner B, Katz S: Na-K-Cl cotransport and Na pump in red cells of young black and blood pressure response to salt loading. J Clin Hypertens 1986;2:101-108.
35. Owen NE: Regulation of Na/K/Cl cotransport in vascular smooth muscle cells. Biochem Biophys Res Commun 1984;125:500-508.
36. - cotransport in cultured endothelial cells. Am J Physiol 1986;250:C888-C895.
37. + fluxes in membrane vesicles from rats of the Milan hypertensive strain. Biochim Biophys Acta 1990;1021:13-20.
38. Weder AB: Membrane sodium transport and salt sensitivity of blood pressure. Hypertension 1991;17[Suppl 1]:174-180.
39. Canessa M, Morgan K, Semplicini A: Genetic differences in lithium-sodium exchange and regulation of the sodium hydrogen exchanger in essential hypertension. J Cardiovasc Pharmacol 1988;12[Suppl 3]:S92-S98.
40. Ruppert M, Diehl J, Kolloch R, et al.: Dietary sodium restriction (DSR) increases serum total and LDL-cholesterol in salt-sensitive (SS) and salt-resistant (SR) normotensive adults (NA). J Hypertens 1990;8[Suppl 3]:S24.
41. Oberman A, Wassertheil-Smoller S, Langford H, et al.: Pharmacologic and nutritional treatment of mild hypertension: Changes in cardiovascular risk status. Ann Intern Med 1990;11:89-95.
42. Williams RR, Hunt SC, Hopkins PN, et al.: Genetic basis of familial dyslipidemia and hypertension: 15-year results from Utah. Am J Hypertens 1993;6:319S-327S